Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Tag: prostate cancer
Sex hormones limit cancer immunotherapy success
Scientists have discovered how the sex hormone androgen, most commonly testosterone in men, can limit the body’s response to cancer immunotherapy, a finding that may help make those therapies more...
New clues to what turns prostate cancers deadly
Only a fraction of prostate cancers become life threatening, but it’s impossible to predict which ones. In a surprising new study, researchers found that two signaling proteins used by nerve cells...
Targeted ‘radioligand’ improves survival in advanced prostate cancer
Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy. The injected treatment...
For veterans with prostate cancer, a new center of excellence in Oregon
VA Portland Health Care System and OHSU are launching a precision oncology center of excellence supported by the Prostate Cancer Foundation. On Veteran's Day, the foundation announced $5 million in...
Interrogating cancer, one cell at a time: Q&A with Hisham Mohammed
Hisham Mohammed, Ph.D., helped create a way to peer into individual cells and take multiple measures of gene activity and gene regulation at the same time. He’s leading the first research to apply...
Researchers uncover how deadly prostate cancers are programmed to resist treatment
A clinical trial at OHSU and UC San Francisco points the way to potential targeted therapies. The drug enzalutamide is a mainstay of treatment for men with life-threatening prostate cancer that has...
Advancing immunotherapy for life-threatening prostate cancer
Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...
Top papers in prostate cancer co-authored by OHSU faculty
Physician-scientists with the OHSU Knight Cancer Institute co-authored three of the 25 most important prostate cancer studies published this year, and one runner up, as judged by the Prostate Cancer...
These prostate cancer researchers are using gut bacteria to fight tumors
Cancer researchers at OHSU have been awarded $1 million to test the idea that adjusting the diversity of bacteria inhabiting the intestines could make aggressive prostate cancers more responsive to...
Exercise study aims to ameliorate the adverse effects of prostate cancer therapy
A clinical trial getting underway at OHSU will compare two types of exercise – tai chi versus strength training – as a means to prevent falls and injuries in men who've received androgen...